Maureen Deehan
Vorstandsvorsitzender bei Vivtex Corp.
Aktive Positionen von Maureen Deehan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Vivtex Corp. | Vorstandsvorsitzender | 21.02.2023 | - |
| Geschäftsführer | 01.12.2022 | 21.02.2023 |
Karriereverlauf von Maureen Deehan
Ehemalige bekannte Positionen von Maureen Deehan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | 01.06.2018 | - |
Ausbildung von Maureen Deehan
| University of Glasgow School of Medicine | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Norwegen | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Börse
- Insiders
- Maureen Deehan
- Erfahrung
